Mirza Mansoor Raza bought ACRV
October 1, 2025 · Form 4 insider transaction
Mirza Mansoor Raza bought 225,000 shares of Acrivon Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
225,000
Price
$0.00
Total value
N/A
InsiderMirza Mansoor Raza
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 1, 2025
Filing dateOctober 3, 2025
Shares owned after225,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Twenty-five percent (25%) of the shares subject to the option vest on November 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.